Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Karyopharm Therapeutics Inc. | 958,131 | reported | 29 Mar 2022 | tx 253+4,374,952−1,873,700 |
| Acrivon Therapeutics, Inc. | 9,366 | reported | 18 May 2026 | tx 4+85,151 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 18 May 2026 | GRANT_AWARD | Acrivon Therapeutics, Inc. | 9,366 | 0.00 USD | |
| 13 Jun 2025 | GRANT_AWARD | Acrivon Therapeutics, Inc. | 20,275 | 0.00 USD | deriv |
| 20 Jun 2024 | GRANT_AWARD | Acrivon Therapeutics, Inc. | 20,275 | 0.00 USD | deriv |
| 14 Nov 2022 | GRANT_AWARD | Acrivon Therapeutics, Inc. | 35,235 | 0.00 USD | deriv |
| 29 Mar 2022 | GRANT_AWARD | Karyopharm Therapeutics Inc. | 60,000 | 0.00 USD | |
| 29 Mar 2022 | GRANT_AWARD | Karyopharm Therapeutics Inc. | 90,000 | 0.00 USD | deriv |
| 28 Feb 2022 | GRANT_AWARD | Karyopharm Therapeutics Inc. | 21,000 | 0.00 USD | |
| 28 Feb 2022 | SALE | Karyopharm Therapeutics Inc. | 6,226 | 10.24 USD | |
| 28 Feb 2022 | SALE | Karyopharm Therapeutics Inc. | 6,226 | 10.24 USD | |
| 28 Feb 2022 | GRANT_AWARD | Karyopharm Therapeutics Inc. | 27,000 | 0.00 USD | deriv |
| 17 Feb 2022 | SALE | Karyopharm Therapeutics Inc. | 9,079 | 12.12 USD | |
| 17 Feb 2022 | SALE | Karyopharm Therapeutics Inc. | 9,088 | 12.12 USD | |
| 07 Feb 2022 | SALE | Karyopharm Therapeutics Inc. | 6,707 | 9.86 USD | |
| 07 Feb 2022 | SALE | Karyopharm Therapeutics Inc. | 6,764 | 9.86 USD | |
| 18 Mar 2021 | SALE | Karyopharm Therapeutics Inc. | 4,000 | 12.39 USD | |
| 25 Feb 2021 | GRANT_AWARD | Karyopharm Therapeutics Inc. | 57,200 | 0.00 USD | |
| 25 Feb 2021 | GRANT_AWARD | Karyopharm Therapeutics Inc. | 57,200 | 0.00 USD | |
| 25 Feb 2021 | GRANT_AWARD | Karyopharm Therapeutics Inc. | 153,500 | 0.00 USD | deriv |
| 25 Feb 2021 | GRANT_AWARD | Karyopharm Therapeutics Inc. | 153,500 | 0.00 USD | deriv |
| 18 Feb 2021 | SALE | Karyopharm Therapeutics Inc. | 9,495 | 14.83 USD | |
| 18 Feb 2021 | SALE | Karyopharm Therapeutics Inc. | 9,495 | 14.83 USD | |
| 15 Feb 2021 | EXERCISE | Karyopharm Therapeutics Inc. | 21,800 | — | |
| 11 Feb 2021 | SALE | Karyopharm Therapeutics Inc. | 6,601 | 15.52 USD | |
| 15 Feb 2021 | EXERCISE | Karyopharm Therapeutics Inc. | 21,800 | — | |
| 11 Feb 2021 | SALE | Karyopharm Therapeutics Inc. | 6,642 | 15.52 USD |